A controversial startup that charges $8,000 to fill your veins with young blood and halted operations after an FDA warning now says it’s back up and running

We found this article at:

www.businessinsider.nl/young-blood-transfusions-ambrosia-emailing-customers-after-regulatory-warning-2019-6-2/